Skip to main content
Clinical Trials/ISRCTN27770434
ISRCTN27770434
Completed
N/A

ormal hearing tinnitus sound therapy: an interventional single-centre study

Oticon A/S0 sites20 target enrollmentApril 21, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
ormal hearing persons with tinnitus symptoms
Sponsor
Oticon A/S
Enrollment
20
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

  1. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/29336133 (added 24/01/2019)
Registry
who.int
Start Date
April 21, 2015
End Date
December 1, 2015
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oticon A/S

Eligibility Criteria

Inclusion Criteria

  • 1\. Normal hearing or hearing loss not more than 25 dB between 250 Hz and 2 kHz
  • 2\. Minimum 6 months tinnitus (no upper limit)
  • 3\. Category 1 (Jastreboff \& Hazell, 2004\) patients with normal hearing and severe tinnitus
  • 4\. Age 18\-75 years
  • 5\. Inclusion of mono or bilateral tinnitus and with moderate hyperacusis (up to 6 in VAS scale), exclusion of pathological severe anxiety and depression (THI \>\= 80\)

Exclusion Criteria

  • All tinnitus aetiology excluding: Meniere, middle\-external ear desease, somatosensory tinnitus under physical therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials